ReadyGo
ReadyGo has developed a pen-like device that has been adapted to help with Covid-19 detection. The device allows for testing of multiple infections, including distinguishing between coronavirus and influenza, and also testing for viral conjunctivitis, herpes and dengue fever.
ReadyGo has raised €948k across 2 funding rounds from 3 investors, most recently a round in Mar 2025. Based in Bath, UK; active in Healthtech. Data as of 28 Oct 2026.
Bath, UKwww.readygotest.com ↗
Total raised
€948k
€947,874
Funding rounds
2
Investors
3
distinct backers
Active since
2021-06
latest 2025-03
Funding by year
EUR raised per yearReadyGo — funding by year — interactive chart.
Data table
| ReadyGo — funding by year | |
|---|---|
| 2021 | €351k |
| 2025 | €597k |
Signals
High confidenceRaise-next likelihood42
base rate 30% for Other
- ▲ In typical raise window
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood6
base rate 11% (2+ rounds)
- ▲ 5y since founding (typical exit age)
- ▼ No recent equity round (debt-only or quiet)
Timing: in window vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-03-06 | Other | €597k | British Business Bank’s South West Investment Fund (SWIF),Maven Capital Partners | View deal → |
| 2021-06-23 | Other | €351k | Foresight Group | View deal → |